These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3580113)

  • 1. A functional separation of behavioral stereotypy based on naloxone-reversible effects of seryl enkephalinamide: comparison with morphine.
    Broderick PA; Blaha CD; Lane RF
    Behav Brain Res; 1987 Apr; 24(1):31-8. PubMed ID: 3580113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of naloxone and morphine on dopamine agonist-induced stereotypy in rats and guinea pigs.
    Feigenbaum J; Yanai J; Moon B; Klawans H
    Neuropharmacology; 1983 Dec; 22(12A):1369-76. PubMed ID: 6686653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion.
    Broderick PA; Gardner EL; van Praag HM
    Biol Psychiatry; 1984 Jan; 19(1):45-54. PubMed ID: 6538442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral activating effects of opiates and opioid peptides.
    Browne RG; Segal DS
    Biol Psychiatry; 1980 Feb; 15(1):77-86. PubMed ID: 6101965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of naloxone, metenkephalin, and morphine on phencyclidine-induced behavior in the rat.
    Castellani S; Giannini AJ; Adams PM
    Psychopharmacology (Berl); 1982; 78(1):76-80. PubMed ID: 6815700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of amphetamine-induced locomotor stereotypy in an open field.
    Mueller K; Kunko PM; Whiteside D; Haskett C
    Psychopharmacology (Berl); 1989; 99(4):501-7. PubMed ID: 2594917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of total horizontal activity and ambulation in rats treated with combinations of beta-phenylethylamine and naloxone.
    Dourish CT; Cooper SJ
    Neuropharmacology; 1984 Sep; 23(9):1059-64. PubMed ID: 6096756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the role of dopamine D1 receptors in morphine induced stereotypic behavior.
    Pollock J; Kornetsky C
    Neurosci Lett; 1989 Jul; 102(2-3):291-6. PubMed ID: 2682389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phencyclidine-induced stereotype in rats: effects of methadone, apomorphine, and naloxone.
    Verebey K; Kogan MJ; Mulè SJ
    Psychopharmacology (Berl); 1981; 75(1):44-7. PubMed ID: 6795658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone-reversible effects of d-Ala2-Met5-enkephalinamide-induced behavioral activity in rats.
    Harston CT; Spirtes MA; Dunlap WP; Coy DH
    Behav Neural Biol; 1980 Sep; 30(1):1-19. PubMed ID: 7447858
    [No Abstract]   [Full Text] [Related]  

  • 12. Patterns of locomotor and stereotypic behavior during continuous amphetamine administration in rats.
    Hollingsworth EM; Mueller K
    Pharmacol Biochem Behav; 1988 Jun; 30(2):535-7. PubMed ID: 3174785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo electrochemical evidence for an enkephalinergic modulation underlying stereotyped behavior: reversibility by naloxone.
    Broderick PA; Blaha CD; Lane RF
    Brain Res; 1983 Jun; 269(2):378-81. PubMed ID: 6683987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of midbrain stimulation on amphetamine-induced stereotypy in rats.
    Tasman A; Simon RH
    Psychopharmacology (Berl); 1983; 79(4):364-6. PubMed ID: 6407053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between enkephalin and dopamine in the control of locomotor activity in the rat: a new hypothesis.
    Agmo A; de Avila N
    Pharmacol Biochem Behav; 1985 Apr; 22(4):599-603. PubMed ID: 3991768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextro-naloxone counteracts amphetamine-induced hyperactivity.
    Chatterjie N; Sechzer JA; Lieberman KW; Alexander GJ
    Pharmacol Biochem Behav; 1998 Feb; 59(2):271-4. PubMed ID: 9476969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some central effects of opioid antagonists. Part I.
    Skorupska M; Langwiński R
    Pol J Pharmacol Pharm; 1989; 41(5):401-11. PubMed ID: 2577060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
    Tschanz JT; Rebec GV
    Pharmacol Biochem Behav; 1988 Nov; 31(3):519-22. PubMed ID: 3251235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine and amphetamine sensitization in rats demonstrated under moderate- and high-dose NMDA receptor blockade with MK-801 (dizocilpine).
    Ranaldi R; Munn E; Neklesa T; Wise RA
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):192-201. PubMed ID: 10972465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy.
    Clark D; Furmidge LJ; Petry N; Tong ZY; Ericsson M; Johnson D
    Psychopharmacology (Berl); 1991; 105(3):381-92. PubMed ID: 1686815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.